Literature DB >> 12761561

Analysis of an IL-10 polymorphism in idiopathic pulmonary fibrosis.

H A Whittington1, R W Freeburn, S I H Godinho, J Egan, Y Haider, A B Millar.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrotic disorder of the lung parenchyma. We have demonstrated changes in IL-10 protein production by alveolar macrophages (AMs) from patients with IPF, which we hypothesise could be because of an IL-10 gene polymorphism. We have screened the coding sequence and 3' untranslated region of IL-10 for polymorphisms using single-standard conformational polymorphism analysis. A novel polymorphism was identified resulting in a G to A substitution of +43 nucleotides from the start codon changing glycine to arginine at amino acid 15 of the signal peptide sequence. We have introduced the signal peptide mutation into the IL-10 gene and compared secretion of the mutant and wild-type forms after transient transfection of COS-7 cells. Our studies showed that the signal peptide mutation did not have a significant effect on secretion at 24 h post-transfection (P=0.4529 by Mann-Whitney test). However, by 48 h there are significantly lower levels of mutant IL-10 (P=0.0515). There were no differences in the level of cell-associated IL-10 at either 24 or 48 h (P=0.9296 and 0.4268). We suggest that the mutation could affect the efficiency of protein translocation and signal peptide cleavage resulting in lower levels of IL-10 protein secretion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761561     DOI: 10.1038/sj.gene.6363959

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  11 in total

Review 1.  Human Fibrosis: Is There Evidence for a Genetic Predisposition in Musculoskeletal Tissues?

Authors:  Louis Dagneaux; Aaron R Owen; Jacob W Bettencourt; Jonathan D Barlow; Peter C Amadio; Jean P Kocher; Mark E Morrey; Joaquin Sanchez-Sotelo; Daniel J Berry; Andre J van Wijnen; Matthew P Abdel
Journal:  J Arthroplasty       Date:  2020-06-04       Impact factor: 4.757

2.  Expression of the immunomodulator IL-10 in type I pneumocytes of the rat: alterations of IL-10 expression in radiation-induced lung damage.

Authors:  Michael G Haase; Anke Klawitter; Peter Geyer; Gustavo B Baretton
Journal:  J Histochem Cytochem       Date:  2007-08-06       Impact factor: 2.479

3.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

Review 4.  The genetic approach in pulmonary fibrosis: can it provide clues to this complex disease?

Authors:  William E Lawson; James E Loyd
Journal:  Proc Am Thorac Soc       Date:  2006-06

5.  Epstein-Barr virus in oral shedding of children with multiple sclerosis.

Authors:  Carmen Yea; Raymond Tellier; Patrick Chong; Garrett Westmacott; Ruth Ann Marrie; Amit Bar-Or; Brenda Banwell
Journal:  Neurology       Date:  2013-09-06       Impact factor: 9.910

6.  Smoking and idiopathic pulmonary fibrosis.

Authors:  Chad K Oh; Lynne A Murray; Nestor A Molfino
Journal:  Pulm Med       Date:  2012-02-19

7.  Association of FcγRIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression.

Authors:  Stylianos Bournazos; Jacob Grinfeld; Karen M Alexander; John T Murchison; William A Wallace; Pauline McFarlane; Nikhil Hirani; A John Simpson; Ian Dransfield; Simon P Hart
Journal:  BMC Pulm Med       Date:  2010-10-07       Impact factor: 3.317

8.  Fcγ receptor IIIb (CD16b) polymorphisms are associated with susceptibility to idiopathic pulmonary fibrosis.

Authors:  Stylianos Bournazos; Irini Bournazou; John T Murchison; William A Wallace; Pauline McFarlane; Nikhil Hirani; A John Simpson; Ian Dransfield; Simon P Hart
Journal:  Lung       Date:  2010-10-06       Impact factor: 2.584

9.  A Mathematical Model of Idiopathic Pulmonary Fibrosis.

Authors:  Wenrui Hao; Clay Marsh; Avner Friedman
Journal:  PLoS One       Date:  2015-09-08       Impact factor: 3.240

10.  Aerobic Exercise Attenuated Bleomycin-Induced Lung Fibrosis in Th2-Dominant Mice.

Authors:  Adilson Santos Andrade-Sousa; Paulo Rogério Pereira; BreAnne MacKenzie; Manoel Carneiro Oliveira-Junior; Erasmo Assumpção-Neto; Maysa Alves Rodrigues Brandão-Rangel; Nilsa Regina Damaceno-Rodrigues; Elia Garcia Caldini; Ana Paula Pereira Velosa; Walcy Rosolia Teodoro; Ana Paula Ligeiro de Oliveira; Marisa Dolhnikoff; Oliver Eickelberg; Rodolfo Paula Vieira
Journal:  PLoS One       Date:  2016-09-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.